The CD8+CD28+ T cell subset of PBMCs from patients with active SLE expressed a lower level of CTLA-4, suggesting that the CD8+CD28+ T cells with higher activity may result from a lower expression of CTLA-4, which leads to the development of SLE (92) (Figure 3B). This evidence concerns the gene CD8A and systemic lupus erythematosus.